CYPER PHARMA has state-of-the-art research and manufacturing units

Range of Cyper Products

Cyper manifests that sustained growth in the industry can be achieved only through continuous pursuit of innovation and enshrined in the intend of its mission. Located at key strategic points in the National capital territory of Delhi and set amidst 15000 square feet of land, we have three state of the art WHO complied manufacturing units. The availability of quality medicines is vital for man, therefore, his demands cannot be overlooked. The socio-economic factor is of the utmost importance in our planning and decision-making. Banking on research and development, we continue to maintain a steady growth of over 30 million capsules and 120 million tablets per month, that is being used for the domestic market and the spare capacity being utilized for our consumers overseas. We are committed to channelize 4 % of our global sales into R & D to accelerate our development into our specialized areas. The therapeutic focus at R&D is on Anti-biotic, anti-inflammatory, anti-allergic, anti-malarial .... etc

Equipped with the latest technology both in manufacturing and research, our endeavor is to ensure the availability of essential medicines of good quality. Such perception facilitates the evolution of common strategy directed towards safeguarding the interest of both people suffering from diseases and the manufacturer of drugs. Today we are on the cross roads of maintaining the ethos of the demands of Indian healthcare systems and on the other hand to adopt itself to the fast changing and highly competitive environment.

Cyper laboratory is equipped with sophisticated equipment like HPLC, UV spectophotometer, Potentiometer, laminar flow bench, BOD incubator in order to test for conformity with BP, USP, IP as well as in-house specification surpassing various pharmacopoeial standards. We also have a well-equipped microbiological laboratory for analysis.